top of page
![](https://static.wixstatic.com/media/61bd14_ddfefdca8c49456eb7f756ffd79c31bf.jpg/v1/fill/w_288,h_180,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/61bd14_ddfefdca8c49456eb7f756ffd79c31bf.jpg)
![](https://static.wixstatic.com/media/61bd14_5052789b9e4d4c8b95c365c3b900766a.png/v1/fill/w_277,h_67,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/61bd14_5052789b9e4d4c8b95c365c3b900766a.png)
Important Anouncement
Management reform in 2020
A joint venture, combining United Biologics Inc (UBI) with financial firms and manufacturers, is under process. The joint venture is expected to harness benefits from Clean Sheet advanced bio-material. Financial & manufacturing professionals will be added to the core staffing in the joint venture.
Building on existing UBI's achievements, the new management will make UBI more effective and more accountable - to both shareholders and customers.
Mr Jefferey Dessau is the authorized representative for the business development of United Biologics Inc. You can reach him at: jeff.dessau@ubio.ca
A ceremony of international cooperation in Canada
![](https://static.wixstatic.com/media/61bd14_1c05869a028c45ff8f9f8c844fdc0b68.jpg/v1/fill/w_414,h_290,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/61bd14_1c05869a028c45ff8f9f8c844fdc0b68.jpg)
AKM
XCM
bottom of page